Search form

Search

Navigation

home
boards
job center
job ratings
cp wire
device news
trending now
- trending in pharma/biotech
- trending in device
pharmagather
advertise
contact us

You are here

Home » Amgen Defends Drug Pipeline, Says the Best is Yet to Come

Amgen Defends Drug Pipeline, Says the Best is Yet to Come

Amgen Defends Drug Pipeline, Says the Best is Yet to Come

TheStreet.com

news tags

Abbott Laboratories AbbVie Allergan Amgen Arena Pharmaceuticals AstraZeneca Biogen Idec biotech Bristol-Myers Squibb cancer Celgene China clinical trials devices diabetes drug pricing earnings Eli Lilly Europe FDA generics Gilead Sciences GSK hepatitis C JNJ M&A Medtronic Merck Novartis obesity patents Pfizer Pharma CEOs R&D Roche Sanofi Teva Pharmaceuticals vaccines Valeant Pharmaceuticals Vivus

privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter | social media-pharma | social media-med device | cafebanking

Copyright © 2017,